Stable expression of human inducible nitric oxide synthase in V79 Chinese hamster cells

Biochemical Pharmacology

Volumn 52, Issue 9, 1996, Pages 1365-1374

  Schmalix, Wolfgang A ^a   Singh, J Jaswant ^b   Kapfhammer, Peter ^a   Stadler, Josef ^a   Nüssler, Andreas K ^c   Geller, David A ^d   Billiar, Timothy R ^d   Simmons, Richard L ^d   Greim, Helmut ^a,e   Doehmer, Johannes ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b CSIR INDIAN INSTITUTE OF INTEGRATIVE MEDICINE   (India)

^c UNIVERSITY OF ULM   (Germany)

^d UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^e INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

heterologous expression; human; inhibitors; nitric oxide; nitric oxide synthase; V79 cells

Indexed keywords

AMINOGUANIDINE; ARGININE; COMPLEMENTARY DNA; ENZYME ANTIBODY; N(G) HYDROXYARGININE; N(G) METHYLARGININE; N(G) NITROARGININE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; S METHYLPSEUDOTHIOUREA; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL LINE; CELL STRAIN V 79; CHINESE HAMSTER; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INDUCTION; ENZYME INHIBITION; EXPRESSION VECTOR; GENETIC ENGINEERING; HUMAN; IMMUNOBLOTTING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECOMBINANT DNA TECHNOLOGY;

ANIMALS; CELL LINE; CRICETINAE; CRICETULUS; DNA, COMPLEMENTARY; ENZYME INDUCTION; ENZYME INHIBITORS; ESCHERICHIA COLI; GENE EXPRESSION; GENETIC ENGINEERING; GENETIC VECTORS; HUMANS; IMMUNOHISTOCHEMISTRY; NITRIC OXIDE SYNTHASE; RNA, MESSENGER; TRANSFECTION;

EID: 0030575954     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(96)00458-3     Document Type: Article

References (35)

1. 1. Nathan C, Nitric oxide as a secretory product of mammalian cells. FASEB J 6: 3051-3064, 1992.
2. 2. Schmidt HHHW and Walter U, NO at work. Cell 78: 919-925, 1994.
3. 3. Radomski MW, Palmer RMJ and Moncada S, The role of NO and cGMP in platelet adhesion to vascular endothelium. Biochem Biophys Res Commun 148: 1482-1489, 1987.
4. 4. Schuman EM and Madison DV, A requirement for the intercellular messenger NO in long-term potentiation. Science 254: 1503-1506, 1991.
5. 5. Nathan C and Xie Q-w, Nitric oxide synthases: Roles, tolls, and controls. Cell 78: 915-918, 1994.
6. 6. Khatsenko OG, Gross SS, Rifkind RB and Vane JR, NO is a mediator of the decrease in the cytochrome P450-dependent metabolism caused by immunostimulants. Proc Natl Acad Sci USA 90: 11147-11151, 1993.
7. 7. Stadler J, Trockfeld J, Schmalix WA, Brill T, Siewert JR, Greim HR and Doehmer J, Inhibition of cytochromes P450 1A by NO. Proc Natl Acad Sci USA 91: 3559-3563, 1994.
8. 8. Nava E, Palmer RMJ and Moncada S, Inhibition of NO synthesis in septic shock: How much is beneficial? Lancet 338: 1555-1557, 1991.
9. 9. Petros A, Bennett D and Vallance P, Effect of NO synthase inhibitors on hypotension in patients with septic shock. Lancet 338: 1557-1558, 1991.
10. 10. Geller DA, Lowenstein CJ, Shapiro RA, Nussler AK, Di Silvio M, Wang SC, Nakayama DK, Simmons RL, Snyder SH and Billiar TR, Molecular cloning and expression of inducible NO synthase from human hepatocytes. Proc Natl Acad Sci USA 90: 3491-3495, 1993.
11. 11. Charles IG, Palmer RMG, Hickery MS, Bayliss MT, Chubb AP, Hall VS, Moss DW and Moncada S, Cloning characterization, and expression of a cDNA encoding an inducible NO synthase from the human chondrocyte. Proc Natl Acad Sci USA 90: 11419-11423, 1993.
12. 12. Hokari A, Zenija M and Esumi H, Cloning and functional expression of human inducible NO synthase (NOS) cDNA from gliablastoma cell line A-172. J Biochem 116: 575-581, 1994.
13. 13. Janssens SP, Shimouchi A, Quertermous T, Bloch DB and Bloch KD, Cloning and expression of a cDNA encoding human endothelium-derived relaxing factor/NO synthase. J Biol Chem 267: 14519-14522, 1992.
14. 14. Lamas S, Marsden PA, Li GK, Tempst P and Michel T, Endothelial NO synthase: Molecular cloning and characterization of a distinct constitutive enzyme isoform. Proc Natl Acad Sci USA 89: 6348-6352, 1992.
15. 15. Bredt DS, Hwang PM, Glatt CE, Lowenstein C, Reed RR and Snyder SH, Cloned and expressed NO synthase structurally resembles cytochrome P-450 reductase. Nature 351: 714-718, 1991.
16. 16. Charles IG, Chubb A, Gill R, Clare J, Lowe PN, Holmes LS, Page M, Keeling JG, Moncada S and Riveros-Moreno V, Cloning and expression of rat neuronal NO synthase coding sequence in a baculovirus/insect cell system. Biochem Biophys Res Commun 196: 1481-1489, 1993.
17. 17. Marsh JL, Erfle M and Wykes EJ, The plC plasmid and phage vectors with versatile cloning sites for recombinant selection by insertional inactivation. Gene 32: 481-485, 1984.
18. 1. Proc Natl Acad Sci USA 85: 5769-5773, 1988.
19. 19. Glatt HR, Seidel A, Ribeiro O, Kirkby C, Hirom P and Oesch F, Metabolic activation to a mutagen of 3-hydroxy-trans-7,8-dihydroxy-7,8-dihydrobenzo[a]pyrene. Carcinogenesis 8: 1621-1627, 1987.
20. 20. Nussler AK, Vergani G, Gollin S, Dorko K, Gansauge S, Morris SM Jr, Demetris AJ, Nomoto M, Beger HG and Strom SC, Isolation and characterization of a human hepatic epithelial cell line (AKN-1) from a normal human liver. In Vitro, submitted.
21. 21. de Vera ME, Shapiro RA, Nussler AK, Mudgett JS, Simmons RL, Morris SM, Billiar TR and Geller DA, Transcriptional regulation of human inducible NO synthase (NOS2) gene by cytokines: Initial analysis of the human NOS2 promoter. Proc Natl Acad Sci USA, 93: 1054-1059, 1996.
22. 15N]nitrate in biological fluids. Anal Biochem 126: 131-138, 1982.
23. 23. Bradford MM, A rapid and sensitive method for the quantitation of microgram quantities of protein using the principle of dye binding. Anal Biochem 72: 248-254, 1976.
24. 24. Hanahan D, Studies on transformation of Escherichia coli with plasmids. J Mol Biol 166: 557-580, 1983.
25. 25. Schmalix WA, Mäser H, Kiefer F, Reen R, Wiebel FJ, Gonzalez F, Seidel A, Glatt H, Greim HR and Doehmer J, Stable expression of human cytochrome P450 1A1 in V79 Chinese hamster cells and metabolic activation of benzo[a]pyrene. Eur J Pharmacol 248: 251-261, 1993.
26. 26. Stadler J, Billiar TR, Curren RD, McIntyre LA, Georgescu HE, Simmons RL and Evans CH, Articular chondrocytes synthesize nitric oxide in response to cytokines and lipopolysaccharide. J Immunol 147: 3915-3920, 1991.
27. 27. Szabó C, Southan GJ and Thiemermann C, Beneficial effects and improved survival in rodent models of septic shock with S-methylsothiourea sulfate, a novel, potent and selective inhibitor of inducible NO synthase. Proc Natl Acad Sci USA 91: 12472-12476, 1994.
28. 28. Southan GJ, Szabó C and Thiemermann C, Isothioureas: Potent inhibitors of NO synthases with variable isoform selectivity. Br J Pharmacol 114: 510-516, 1995.
29. 29. Wink DA, Kasprzak KS, Maragos CM, Elespuru RK, Misra M, Dunams TM, Cebula TA, Koch WH, Andrews AW, Allen JS and Keefer LK, DNA deaminating ability and genotoxicity of NO and its progenitors. Science 254: 1001-1002, 1991.
30. 30. Stuehr DJ and Nathan CF, NO: A macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells. J Exp Med 169: 1543-1545, 1989.
31. 31. Nathan C and Hibbs JB Jr, Role of NO synthesis in macrophage antimicrobial activity. Curr Opin Immunol 3: 65-70, 1991.
32. 32. Lambert LE, Whitten JP, Baron BM, Cheng HC, Doherty NS and McDonald IA, NO synthesis in the CNS, endothelium and macrophages differs in its sensitivity to inhibition by arginine analogues. Life Sci 48: 69-75, 1991.
33. 33. Gross SS, Jaffe EA, Levi R and Kilbourn RG, Cytokine-activated endothelial cells express an isotype of NO synthase which is tetrahydrobiopterin-dependent, calmodulin-independent and inhibited by arginine-analogs with a rank order characteristic of activated macrophages. Biochem Biophys Res Commun 178: 823-829, 1991.
34. 34. Sherman PA, Laubach VE, Reep BR and Wood ER, Purification and cDNA sequence of an inducible NO synthase from a human tumor cell line. Biochemistry 32: 11600-11605, 1993.
35. 35. Szabo C, Southan GJ, and Thiemermann C, Beneficial effect and improved survival in rodent models of septic shock with S-methylisothiourea sulfate, a potent and selective inhibitor of inducible nitric oxide synthase. Proc Natl Acad Sci USA 91: 12472-12476, 1994.